The firm did not go into specifics on the new capacity - which is mirrored at its US HQ in Souderton, Pennsylvania – but did predict that it will be of interest to "existing and potential clients where maintaining temperature control is critical to the shelf life and stability of their compound or the chosen comparator.”
Commenting on the developmet Martin Lamb, VP of Business Development, said “Our suite of leading cold chain solutions is a response to the growing customer demand for clinical services for temperature sensitive materials.
“Our goal is to provide closed loop cold-chain solutions tailored towards our customer’s individual needs, remaining mindful that we are servicing an industry wherein effectiveness and efficiency are increasingly sought after attributes.”
The expansion comes a little over a year after Almac began ramping up cold-storage capacity for clinical trial supplies at Craigavon in a project that was also motivated by client demand.
In that instance the Northern Irish CMO and the customer – an unnamed US monoclonal antibody maker working in the areas of cancer and autoimmune disease– both invested to fund the construction of 6,124sqft of storage capacity.
In broader terms the investment in refrigerator capacity is one of several Almac has made in the storage and logistics side of its business since 2010 when it launched its STEMS temperature controlled monitoring system for clinical trial supplies.
Since then the firm has rolled out a supply forecasting system – Compass – for its manufacturing clients and opened a dedicated clinical trial supplies centre to co-ordinated and manage supplies at its 36-strong network of storage depots around the world, the newest of which were opened in Japan, Thailand, Hong Kong, Taiwan in June last year.